Pfizer, BioNTech sign deal to supply BNT162 Covid-19 vaccine to Canada

pharmanewsdaily- August 6, 2020 0

Pfizer and BioNTech have signed an agreement with the Canadian government to supply their mRNA-based BNT162 vaccine candidate against SARS-CoV2, depending on clinical success and ... Read More